Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- Check6 days agoChange DetectedFooter revision updated from v3.6.6 to v3.7.0, indicating a new version of the page. This update reflects a backend/content management change rather than any modification to the study data or eligibility criteria.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision label has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page's revision tag in the footer was updated from v3.6.4 to v3.6.5, indicating a minor metadata update to the page.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now displays a newer revision number (v3.6.4) in place of the previous v3.6.3, indicating a small update to the site's interface.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, indicating a newer version of the page has been published. This suggests a minor update to the page metadata or content.SummaryDifference0.1%

- Check106 days agoChange DetectedRecruitment status on the study page now indicates no longer looking for participants. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label formatting plus the page revision to v3.6.0 (from v3.5.4) were updated.SummaryDifference0.5%

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.